J Appl Biomed 6:47-56, 2008 | DOI: 10.32725/jab.2008.007

Genetically altered mice, man and medicine

Nirmala Bhogal*
FRAME, Nottingham, United Kingdom

Several million genetically altered mice are used worldwide each year for research, toxicity testing, or simply to create or sustain mutant models. In fact, as our understanding of the genetic differences between mice and men improves, so does the drive to create mouse models of human disease and toxicity. However, while some models have proven to be useful and confer tangible benefits in terms of clinical management of disease, many others add little value to clinical medicine or human safety emphasising the need for a thorough investigation of the actual or future value of such models to human medicine.

Keywords: disease; genetically altered; mouse; mutant; welfare

Received: February 6, 2008; Revised: March 10, 2008; Published: July 31, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bhogal N. Genetically altered mice, man and medicine. J Appl Biomed. 2008;6(2):47-56. doi: 10.32725/jab.2008.007.
Download citation

References

  1. Ablamunits V, Elias D, Reshef T, Cohen IR: Islet T cells secreting IFN-gamma in NOD mouse diabetes: arrest by p277 peptide treatment. J. Autoimmun. 11:73-81, 1998. Go to original source... Go to PubMed...
  2. Akeson EC, Lambert JP, Narayanswami S, Gardiner K, Bechtel LJ, Davisson MT: Ts65Dn-localization of the translocation breakpoint and trisomic gene content in a mouse model for Down syndrome. Cytogenet. Cell Genet. 93:270-276, 2001. Go to original source... Go to PubMed...
  3. Ameen N, Alexis J, Salas P: Cellular localisation of the cystic fibrosis transmembrane conductance regulator in mouse intestinal tract. Histochem. Cell Biol. 114:69-75, 2000. Go to original source... Go to PubMed...
  4. Artandi SE, Chang S, Lee SL, Alson S, Gottlieb GJ, Chin L, DePinho RA: Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 406:641-645, 2000. Go to original source... Go to PubMed...
  5. Attardi LD, Jacks T: The role of p53 in tumour suppression: lessons from mouse models. Cell. Mol. Life Sci. 55:48-63, 1999. Go to original source... Go to PubMed...
  6. Ayash-Rashkovsky M, Bentwich Z, Arditti F, Friedman S, Reisner Y, Borkow G: A novel small animal model for HIV-1 infection. FASEB J.19: 1149-1151, 2005. Go to original source... Go to PubMed...
  7. Bacchus C, Sterz H, Buselmaier W, Sahai S, Winking H: Genesis and systematization of cardiovascular anomalies and analysis of skeletal malformations in murine trisomy 16 and 19: Two animal models for human trisomies. Hum. Genet. 77:12-22, 1987. Go to original source... Go to PubMed...
  8. Boot HJ, Kasteel DTJ, Buisman A-M, Kimman TG: Excretion of wild-type and vaccine-derived poliovirus in the faeces of poliovirus receptor-transgenic mice. J. Virol. 77:6541-6545, 2003. Go to original source... Go to PubMed...
  9. Chang LJ, Zhang C: Infection of replication of Tat- human immunodeficiency viruses: Genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells. Virology 211:157-169, 1995. Go to original source... Go to PubMed...
  10. Cox DR, Palmiter RD: Assignment of the mouse metallothionein-1 gene to chromosome-8: Implications for human Menkes disease. Clin. Res. 30:A117-A117, 1982. Go to original source... Go to PubMed...
  11. Cryan JF, Mombereau C: In search of a depressed mouse: utility of models for studying depression-related behaviour in genetically modified mice. Mol. Psychiatry 9:326-357, 2004. Go to original source... Go to PubMed...
  12. Daingain J, Vrbova G: Muscle development in mdx GA mice. Muscle Nerve 7: 700 - 704, 1984. Go to original source... Go to PubMed...
  13. Dalke C, Graw J: Mouse mutants as models for congenital retinal disorders. Exp. Eye Res. 81: 503 - 512, 2005. Go to original source... Go to PubMed...
  14. Dragunsky E, Nomura T, Karpinski K, Furesz J, Wood DJ, Perivikov Y, Abe S, Kurata T, Vanloocke O, Karganova G, Taffs R, Heath A et al.: Transgenic mice as an alternative to monkeys for neurovirulence testing of live oral poliovirus vaccine: Validation by a WHO collaborative study. Bull. World Health Org. 81:251-262, 2003.
  15. ElAmraoui A, Sahly I, Picaud S, Sahel J, Abitbol M, Petit C: Human Usher 1B mouse shaker-1: The retinal phenotype discrepancy explained by the presence/absence of myosin VIIA in the photoreceptor cells. Hum. Mol. Genet. 5:1171-1178, 1996. Go to original source... Go to PubMed...
  16. Elias D, Meilin A, Ablamunits V, Birk OS, Carmi P, Könen-Waisman S, Cohen IR: Hsp60 peptide therapy of NOD mouse diabetes induces a Th2 cytokine burst and downregulates autoimmunity to various ß-cell antigens. Diabetes 46:758-764, 1997. Go to original source... Go to PubMed...
  17. Epstein CJ, Cox DR, Epstein LB: Mouse trisomy 16: An animal model of human trisomy 21 (Down syndrome). Ann. N. Y. Acad. Sci. 450:157-168, 1985. Go to original source... Go to PubMed...
  18. Fletcher S, Honeyman K, Fall AM, Harding PL, Johnsen RD, Steinhaus JP, Moulton HM, Iversen PL, Wilton SD: Morpholino oligomer-mediated exon skipping averts the onset of dystrophic pathology in the mdx mouse. Mol. Ther. 15:1587-1592, 2007. Go to original source... Go to PubMed...
  19. Gardner KL, Kearney JA, Edwards JD, Rafael-Fortney JA: Restoration of all dystrophin protein interactions by functional domains in trans does not rescue dystrophy. Gene Ther. 13:744-751, 2006. Go to original source... Go to PubMed...
  20. Gibson F, Walsh J, Mburu P, Varela A, Brown KA, Antonio M, Beisel KW, Steel KP, Brown SD: A type VII myosin encoded by the mouse deafness gene shaker-1. Nature 374:62-64, 1995. Go to original source... Go to PubMed...
  21. Gotz J, Chen F, van-Dorpe J, Nitsch RM: Tau filament formation in transgenic mice expressing P301L tau. J. Biol. Chem. 276:529-534, 2001. Go to original source... Go to PubMed...
  22. Greaves DR, Fraser P, Vidal MA, Hedges M, Ropers D, Luzzatto L, Grosveld F: A transgenic mouse model of sickle cell disorder. Nature 11:183-185, 1990. Go to original source... Go to PubMed...
  23. Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 100:57-70, 2000. Go to original source... Go to PubMed...
  24. Hanna J, Wernig M, Markoulaki S, Sun C-W, Meissner A, Cassady JP, Beard C, Brambrink T, Wu L-C, Townes TM, Jaenisch R: Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318:1920-1923, 2007. Go to original source... Go to PubMed...
  25. Hiota C, Larsson O, Shelton KD, Shiota M, Efanov AM, Hoy M, Lindner J, Kooptiwut S, Juntti-Berggren L, Gromada J, Berggren P-O, Magnuson MA: Sulfonylurea receptor type 1 knock-out mice have intact feeding-stimulated insulin secretion despite marked impairment in their response to glucose. J. Biol. Chem. 277:37176-37183, 2002. Go to original source... Go to PubMed...
  26. Holcomb L, Gordon MN, McGowan E, Yu X, Benkovic S, Jantzen P, Wright K, Saad I, Mueller R, Morgan D, Sanders S, Zehr C, O' Campo K, Hardy J, Prada C-M, Eckman C, Younkin S, Hsiao K, Duff K: Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenelin 1 transgenes. Nat. Med. 4:97-100, 1998. Go to original source... Go to PubMed...
  27. Holtzman DM, Santucci D, Kilbridge J, Chua-Couzens J, Fontana DJ, Daniels SE, Johnson RM, Chen K, Sun Y, Carlson E, Alleva E, Epstein CJ, Mobley WC: Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome. Proc. Natl. Acad. Sci. U.S.A. 93:13333-13338, 1996. Go to original source... Go to PubMed...
  28. Hunter CL, Bimonte-Nelson HA, Nelson M, Eckman CB, Granholm A-C: Behavioral and neurobiological markers of Alzheimer's disease in Ts65Dn mice: effects of estrogen. Neurobiol. Aging 25:873-884, 2004. Go to original source... Go to PubMed...
  29. International Human Genome Sequencing Consortium: Initial sequencing and analysis of the human genome. Nature 409:860-921, 2001. Go to original source... Go to PubMed...
  30. Jacobs GH, Neitz J, Deegan JF: Retinal receptors in rodents maximally sensitive to ultraviolet light. Nature 353:655-656, 1991. Go to original source... Go to PubMed...
  31. Jacobson-Kram D, Sistare FD, Jacobs AC: Use of transgenic mice in carcinogenicity hazard assessment. Toxicol. Pathol. 32 (Suppl.1):49-52, 2004. Go to original source... Go to PubMed...
  32. Jenkins ES, Combes RD: The welfare problems associated with using transgenic mice to bioassay for bovine spongiform encephalopathy. Anim. Welf. 8:421-431, 1999. Go to original source... Go to PubMed...
  33. Kanezaki Y, Obata T, Matsushima R, Minami A, Yuasa T, Kishi K, Bando Y, Uehara H, Izumi K, Mitani T, Matsumoto M, Takeshita Y et al.: KATP channel knockout mice crossbred with transgenic mice expressing a dominant negative form of human insulin receptor have glucose intolerance but not diabetes. Endocr. J. 51:133-144, 2004. Go to original source... Go to PubMed...
  34. Kerem B, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, Buchwald M, Tsui LC: Identification of the cystic fibrosis gene: genetic analysis. Science 245:1073-1080, 1989. Go to original source... Go to PubMed...
  35. Kroese ED, van Steeg H, van Oostrom CT, Dortant PM, Wester P, van Kranen HJ, de Aries A, van Kreijl CF: Use of E-pim transgenic mice for short-term in vivo carcinogenicity testing: Iymphoma induction by benzo[a]pyrene but not TPA. Carcinogenesis 19:975-908, 1997. Go to original source... Go to PubMed...
  36. Kunzelmann K, Schreiber R, König J, Mall M: Ion transport induced by proteinase-activated receptors (PAR2) in colon and airways. Cell Biochem. Biophys. 36:209-214, 2002. Go to original source... Go to PubMed...
  37. Lundkvist J, Zhu S, Hansson EM, Schweinhardt P, Qing M, Beatus P, Dannaeus K, Karlstrom H, Johansson CB, Viitanen M, Rozell B, Spenger C, Mohammed A, Kalimo H, Lendahl U: Mice carrying a R142C Notch 3 knock-in mutation do not develop a CADASIL-like phenotype. Genesis 41:13-22, 2004. Go to original source... Go to PubMed...
  38. MacDonald JS: Human Carcinogenic Risk Evaluation, Part IV: Assessment of human risk of cancer from chemical exposure using a global weight-of-evidence approach. Toxicol. Sci. 82:3-8, 2004. Go to original source... Go to PubMed...
  39. MacLaren RE, Pearson RA, MacNeil A, Douglas RH, Salt TE, Akimoto M, Swaroop A, Sowden JC, Ali RR: Retinal repair by transplantation of photoreceptor precursors. Nature 444:203-207, 2006. Go to original source... Go to PubMed...
  40. Mall M, Grubb BR, Harkema JR, O'Neal WK, Boucher RC: Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice. Nat. Med. 10:487-493, 2004. Go to original source... Go to PubMed...
  41. Manci EA, Hilliery CA, Bodian CA, Zhang ZG, Lutty GA, Coller BS: Pathology of Berkeley sickle cell mice: similarities and differences with human sickle cell disease. B lood 107:1651-1658, 2006. Go to original source... Go to PubMed...
  42. Mansour SL, Thomas KR, Capecchi MR: Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature 336:348-352, 1988. Go to original source... Go to PubMed...
  43. Meuleman P, Libbrecht L, De Vos R, de Hemptinne B, Gevaert K, Vandekerckhove J, Roskams T, Leroux-Roels G: Infection by proxy: The role of chimeric mice in HBV and HCV research. Morphological and biochemical characterization of a human liver in a uPASCID mouse chimera. Hepatology 41:847-856, 2005. Go to original source... Go to PubMed...
  44. Mouse Genome Sequencing Consortium: Initial sequencing and comparative analysis of the mouse genome. Nature 420:520-562, 2002. Go to original source... Go to PubMed...
  45. O'Doherty A, Ruf S, Mulligan C, Hildreth V, Errington ML, Cooke S, Sesay A, Modino S, Vanes L, Hernandez D, Linehan JM, Sharpe PT et al.: An aneuploid mouse strain carrying human chromosome 21 with Down syndrome phenotypes. Science 309:2033-2037, 2005. Go to original source... Go to PubMed...
  46. Paszty C, Brion CM, Manci E, Witowska HE, Stevens ME, Mohandas N, Rubin EM: Transgenic knockout mice with exclusively human sickle haemoglobin and sickle cell disease. Science 278:876-878, 1997. Go to original source... Go to PubMed...
  47. Rozmahel E, Gyomorey K, Plyte S, Nguyen V, Wilschanski M, Durie P, Bear CE, Tsui LC: Incomplete rescue of cystic fibrosis transmembrane conductance regulator deficient mice by the human CFTR cDNA. Hum. Mol. Genet. 6:1153-1162, 1997. Go to original source... Go to PubMed...
  48. Satokata I, Maas R: Msx-1 deficient mice exhibit cleft palate and abnormalities of craniofacial and tooth development. Nat. Genet. 6:348-356, 1994. Go to original source... Go to PubMed...
  49. Shichor T, Crawford M, Engelhardt T, Bell G, Bell D, Carmichael FJL, Kim PCW: HRC 101 improves survival during hypoxia in SAD mice. Can. J. Anesth. 54:44491, 2007. Go to original source...
  50. Sung C-H, Makino C, Baylor D, Nathans J: A rhodopsin gene mutation responsible for autosomal dominant retinitis pigmentosa results in a protein that is defective in localization to the photoreceptor outer segment. J. Neurosci. 14:5818-5833, 1994. Go to original source... Go to PubMed...
  51. Trudel M, Saadane N, Garel MC, Bardakdjian-Michau J, Blouquit Y, Guerquin-Kern JL, Rouyer-Fessard P, Vidaud D, Pachnis A, Romeo PH, Beuzard Y, Costantini F: Towards a transgenic mouse model of sickle cell disease - Hemoglobin SAD. EMBO J. 10:3157-3165, 1991. Go to original source...
  52. Wahnschaffe U, Bitsch A, Kielhorn J, Mangelsdorf I: Mutagenicity testing with transgenic mice. Part I: Comparison with the mouse bone marrow micronucleus test. J. Carcinog. 4: 3, 2005. doi: 10.1186/1477-3163-4-3 Go to original source... Go to PubMed...
  53. Wicker LS, Clark J, Fraser HI, Garner VES, Gonzalez-Munoz A, Healy B, Howlett S, Hunter K, Rainbow D, Rosa RL, Smink LJ, Todd JA et al.: Type 1 diabetes genes and pathways shared by humans and NOD mice. J. Autoimmun. 25:29-33, 2005. Go to original source... Go to PubMed...
  54. Yamamoto S, Mitsumori K, Kodama Y, Matsunuma N, Manabe S, Okamiya H, Suzuki H, Fukuda T, Sakamaki Y, Sunaga M, Nomura G, Hioki K et al.: Rapid induction of more malignant tumors by various genotoxic carcinogens in transgenic mice harboring a human prototype c-Ha-ras gene than in control non-transgenic mice. Carcinogenesis 17:2455-2461, 1996. Go to original source... Go to PubMed...